Search Results

Eli Lilly and Co. has agreed to pay $18 million to settle a bitter dispute it had with New York-based Emisphere Technologies Inc. Emisphere announced the settlement agreement this morning but gave no details. The agreement still needs approval from U.S. District Court Judge David Hamilton in Indianapolis. In January 2006, Hamilton ruled that Indianapolis-based […]

Fineline Printing Group in Indianapolis has spent $2.5 million on a Heidelberg Speedmaster printing press, an investment that will require hiring 25 more workers in the next two years, Fineline said yesterday. The German-built offset press is the most productive in its class, said Fineline, which is on the northwestside. Family-owned Fineline counts Eli Lilly […]

Indianapolis-based Eli Lilly and Co. is suing Sun Pharmaceutical Industries Ltd. of India to stop Sun from selling a generic version of its hyper-disorder drug Strattera. Lilly, which filed the suit in Detroit on Sept. 20, said it would be “irreparably harmed” if the generic wasn’t stopped, according to Bloomberg. Sun’s application to the U.S. […]

ParaPRO LLC, a startup specialty pharmaceutical company that’s developing a novel treatment for head lice, has received a $2.1 million grant from the 21st Century Research and Technology Fund, the Indiana Economic Development Corp. announced today. The grant will allow the Carmel company to complete clinical trials of its medicine for head lice and their […]

Sales of Eli Lilly and Co.’s drugs in China are increasing at an even faster clip than the fast-growing nation’s overall pharmaceutical market, Reuters reports. Lilly’s sales are rising about 26 percent a year compared with 16 percent for the entire drug industry in China, the world’s most populous country. Lilly introduced five drugs to […]

Eli Lilly and Co.’s osteoporosis drug Evista has been approved to reduce risk of invasive breast cancer in postmenopausal women with osteoporosis and postmenopausal women at high risk for invasive breast cancer, the Indianapolis drugmaker announced today. The U.S. Food and Drug Administration move came after an FDA advisory panel in late July recommended the […]

Eli Lilly and Co. spent nearly $2 million in the first half of 2007 to lobby the federal government, the Associated Press reported today. The Indianapolis-based drug maker lobbied on issues related to patent reform, intellectual property, counterfeiting, prescription drug user fees, health care reform and Medicare, according to the form posted online Aug. 13 […]

After testing a new kind of wellness program at Eli Lilly and Co., WellPoint Inc. is offering the broad program to all national employers served by its Anthem subsidiary. WellPoint touts its Healthy Lifestyles program as a help to employers trying to get their workers to make healthy behavior changes in five key areas: tobacco […]

Indianapolis-based Eli Lilly and Co. paid more money-$11 million-to Minnesota doctors, nurses and medical foundations than any other drug company between 2002 and 2004, according to the Pioneer Press of St. Paul, Minn. The report is based on Minnesota’s strict disclosure law. Only Maine and Vermont have similar laws requiring pharmaceutical companies to open books […]